Increased sensitivity to the locomotor depressant effect of a dopamine receptor antagonist during cocaine withdrawal in the rat

Psychopharmacology

Volumn 141, Issue 2, 1999, Pages 135-144

  Baldo, Brian A ^a,b   Markou, Athina ^a,b   Koob, George F ^a,b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cis flupenthixol; Cocaine; Dopamine receptor antagonist; Locomotor activity; Psychomotor stimulant; Self administration; Withdrawal

Indexed keywords

COCAINE; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; FLUPENTIXOL;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINE RECEPTOR BLOCKING; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; DOSE RESPONSE; DRUG EFFECT; DRUG SELF ADMINISTRATION; DRUG WITHDRAWAL; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOTOR ACTIVITY; MOTOR DYSFUNCTION; NONHUMAN; OUTCOMES RESEARCH; PRIORITY JOURNAL; RAT;

ANALYSIS OF VARIANCE; ANIMALS; COCAINE; DOPAMINE ANTAGONISTS; FLUPENTHIXOL; MALE; MOTOR ACTIVITY; RATS; RATS, WISTAR; SELF ADMINISTRATION; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS;

EID: 0032953656     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050817     Document Type: Article

References (60)

1. Abelson HI, Miller JD (1985) A decade of trends in cocaine use in the household population. In: Cocaine use in America: epidemiologic and clinical perspectives. NIDA Research Monograph 61, US Government Printing Office, Washington, D.C., pp 35-49
2. Amalric M, Koob GF (1993) Functionally selective neurochemical afferents and efferents of the mesocorticolimbic and nigrostriatal dopamine system. In: Arbuthnott GW, Emson PC (eds) Progress in brain research, vol 99: Chemical signaling in the basal ganglia. Elsevier, N.Y., pp 209-226
3. American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders, 3rd edn - revised. American Psychiatric Association Press, Washington, D.C.
4. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association Press, Washington, D.C.
5. Bauer LO (1993) Motoric signs of CNS dysfunction associated with alcohol and cocaine withdrawal. Psychiatry Res 47:69-77
6. Brower KJ, Maddahian E, Blow FC, Beresford TP (1988) A comparison of self-reported symptoms and DSM-III-R criteria for cocaine withdrawal. Am J Drug Alcohol Abuse 14:347-356
7. Caine SB, Lintz R, Koob GF (1993) Intravenous drug self-administration techniques in animals. In: Saghal A (ed) Behavioral neuroscience: a practical approach. Oxford University Press, Oxford, pp 117-143
8. Cardoso F, Jankovic J (1983) Movement disorders. Neurol Clin 11:625-638
9. Choy-Kwong M, Lipton RB (1989) Dystonia related to cocaine withdrawal: a case report and pathogenic hypothesis. Neurology 39:996-997
10. Cottler LB, Shillington AM, Compton WM III, Mager D, Spitznagel EL (1993) Subjective reports of withdrawal among cocaine users: recommendations for DSM-IV. Drug Alcohol Depend 33:97-104
11. Dackis CA, Gold MS (1985) Bromocriptine as a treatment for cocaine abuse. Lancet 1:1151
12. Daras M, Koppel BS, Atoz-Radzion E (1994) Cocaine-induced choreoathoid movements ("crack dancing"). Neurology 44:751-752
13. Dworkin SI, Co C, Smith JE (1995a) Rat brain neurotransmitter turnover rates altered during withdrawal from chronic cocaine administration. Brain Res 682:116-126
14. Dworkin SI, Mirkis S, Smith JE (1995b) Response-dependent versus response-independent presentation of cocaine: differences in the lethal effects of the drug. Psychopharmacology 117:262-266
15. Emmett-Oglesby MW, Lane JD (1992) Tolerance to the reinforcing effects of cocaine. Behav Pharmacol 3:193-200
16. Ettenberg A, Pettit HO, Bloom FE, Koob GF (1982) Heroin and cocaine intravenous self-administration in rats: mediation by separate neural systems. Psychopharmacology 78:204-209
17. Fung YK, Richard LA (1994) Behavioral consequences of cocaine withdrawal in rats. J Pharm Pharmacol 46:150-152
18. Fuxe K, Hokfelt T, Olson L, Ungerstedt U (1977) Central monoaminergic pathways with emphasis on their relation to the so-called "extrapyramidal motor system". Pharmacol Ther B 3: 169-210
19. Gawin FH (1991) Cocaine addiction: psychology and neurophysiology. Science 251:1580-1586
20. Gawin FH, Kleber HD (1986) Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Arch Gen Psychiatry 43:107-113
21. Geyer MA, Russo PV, Masten VL (1986) Multivariate assessment of locomotor behavior: pharmacological and behavioral analyses. Pharmacol Biochem Behav 25:277-288
22. Giannini JA, Baumgartel P, DiMarzio LR (1987) Bromocriptine therapy in cocaine withdrawal. J Clin Pharmacol 27:267-270
23. Gold MS (1993) Cocaine. Plenum Press, New York and London
24. Grinspoon L, Balakar JB (1976) Cocaine: a drug and its social evolution. Basic Books Inc., N.Y.
25. Grinspoon L, Balakar JB (1980) Drug dependence: non-narcotic agents. In: Kaplan HI, Freedman AM, Sadock BJ (eds) Comprehensive textbook of psychiatry. Williams & Wilkins, Baltimore, Md., pp 1614-1629
26. Handelsman L, Limpitlaw L, Williams D, Schmeidler J, Paris P, Stimmel B (1995) Amantadine does not reduce cocaine use or craving in cocaine-dependent methadone maintenance patients. Drug Alcohol Depend 39:173-180
27. Hegarty AM, Lipton RB, Merriam AE, Freeman K (1991) Cocaine as a risk factor for acute dystonic reactions. Neurology 41:1670-1672
28. Hemby SE, Co C, Koves TR, Smith JE, Dworkin SI (1997) Differences in extracellular dopamine concentrations in the nucleus accumbens during response-dependent and response-independent cocaine administration in the rat. Psychopharmacology 133:7-16
29. Herman ZS, Trzeciak H, Chrusciel TL, Kmieciak-Kolada K, Drybanski A, Sokola A (1971) The influence of prolonged amphetamine treatment and amphetamine withdrawal on brain biogenic amine content and behavior in the rat. Psychopharmacologia 21:74-81
30. Hollander E, Nunes E, DeCaria CM, Quitkin FM, Cooper T, Wager S, Klein DF (1990) Dopaminergic sensitivity and cocaine abuse: response to apomorphine. Psychiatr Res 33:161-169
31. Hornykiewicz O (1966) Dopamine (3-hydroxytyramine) and brain function. Pharmacol Rev 18:925-964
32. Joyce E, Stinus L, Iversen SD (1983) Effects of microinjections of 6OHDA into either nucleus accumbens septi or frontal cortex on spontaneous and drug-induced activity. Neuropharmacology 22:1141-1145
33. Kelley AE, Winnock M, Stinus L (1986) Amphetamine, apomorphine, and investigatory behavior in the rat: analysis of the structure and pattern of responses. Psychopharmacology 88:66-74
34. King GR, Joyner C, Lee T, Kuhn C, Ellinwood EH Jr (1992) Intermittent and continuous cocaine administration: residual behavioral states during withdrawal. Pharmacol Biochem Behav 43:243-248
35. King GR, Kuhn C, Ellinwood EH Jr (1993) Dopamine efflux during withdrawal from continuous or intermittent cocaine. Psychopharmacology 111:179-184
36. 2 receptor function. J Pharmacol Exp Ther 269:743-749
37. Koob GF, Bloom FE (1988) Cellular and molecular mechanisms of drug dependence. Science 242:715-723
38. Koob GF, Swerdlow N, Seeligson M, Eaves M, Sutton R, Rivier J, Vale W (1984) Effects of alpha-flupenthixol and naloxone on CRF-induced locomotor activation. Neuroendocrinology 39:459-464.
39. Kumor K, Sherer M, Jaffe J (1986) Haloperidol-induced dystonia in cocaine addicts. Lancet II:1341-1342
40. Lago JA, Kosten TR (1994) Stimulant withdrawal. Addiction 89:1477-1481
41. Lynch MA, Leonard BE (1978) Effect of chronic amphetamine administration on the behavior of rats in the open field apparatus: reversal of post-withdrawal depression by two antidepressants. J Pharm Pharmacol 30:798-799
42. Markou A, Koob GF (1991) Postcocaine anhedonia: an animal model of cocaine withdrawal. Neuropsychopharmacology 4:17-26
43. Markou A, Koob GF (1992) Bromocriptine reverses the elevations in intracranial self-stimulation thresholds observed in a rat model of cocaine withdrawal. Neuropsychopharmacology 7:213-224
44. McNaughton N (1993) Statistics for behavioral neuroscience. In: Saghal A (ed) Behavioral neuroscience: a practical approach. Oxford University Press, Oxford, pp 169-188
45. Møller Nielsen I, Pedersen V, Nymark M, Franck KF, Boeck V, Fjalland B, Christensen AV (1973) The comparative pharmacology of flupenthixol and some reference neuroleptics. Acta Pharmacol Toxicol 33:353-362
46. Nymark M, Franck KF, Pedersen V, Boeck V, Møller Neilsen I (1973) Prolonged neuroleptic effect of alpha-flupenthixol decanoate in oil. Acta Pharmacol Toxicol 33:363-376
47. Parsons LH, Koob GF, Weiss F (1995) Serotonin dysfunction in the nucleus accumbens of rats during withdrawal after unlimited access to intravenous cocaine. J Pharmacol Exp Ther 274:1182-1191
48. Paulson PE, Camp DM, Robinson TE (1991) Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats. Psychopharmacology 103:480-492
49. Pijnenburg AAJ, Honig WMM, Van Der Heyden JAM, Van Rossum JM (1976) Effects of chemical stimulation of the mesolimbic dopamine system upon locomotor activity. Eur J Pharmacol 35:45-58
50. Pulvirenti L, Koob GF (1993) Lisuride reduces psychomotor retardation during withdrawal from chronic intravenous amphetamine self-administration in rats. Neuropsychopharmacology 8:213-218
51. Roberts LA, Bauer LO (1993) Reaction time during cocaine versus alcohol withdrawal: longitudinal measures of visual and auditory suppression. Psychiatry Res 46:229-237
52. Satel SL, Swann AC (1993) Extrapyramidal symptoms and cocaine abuse. Am J Psychiatry 150:347
53. Satel SL, Price LH, Palumbo JM, McDougle CJ, Krystal JH, Gawin FH, Charney DS, Heninger GR, Kleber HD (1991) Clinical phenomenology and neurobiology of cocaine abstinence: a prospective inpatient study. Am J Psychiatry 148:1712-1716
54. Tennant FS, Sagherian AA (1987) Double-blind comparison of amantadine and bromocriptine for ambulatory withdrawal from cocaine dependence. Arch Int Med 147:109-112
55. Tonge SR (1974) Noradrenaline and 5-hydroxytryptamine metabolism in six areas of rat brain during post-amphetamine depression. Psychopharmacologia 38:181-186
56. Ungerstedt U (1978) The role of dopamine as a neurotransmitter in the central and autonomic nervous system. Acta Endocrinol [Suppl.] 216:13-26
57. Ushijima I, Mizuki Y, Yamada M (1995) Alteration of cataleptic responses induced by dopamine receptor antagonists after chronic cocaine administration in mice. Eur J Pharmacol 285:55-59
58. Volkow ND, Fowler JS, Wolf AP, Hitzemann R, Dewey S (1991) Changes in brain glucose metabolism in cocaine dependence and withdrawal. Am J Psychiatry 148:621-626
59. Weddington WW, Brown BS, Haertzen CA, Cone EJ, Dax EM, Herning RI, Michaelson BS (1990) Changes in mood, craving and sleep during short-term abstinence reported by male cocaine addicts. A controlled, residential study. Arch Gen Psychiatry 47:862-868
60. Weiss F, Markou A, Lorang MT, Koob GF (1992) Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration. Brain Res 593:314-318